Patient Demographics > Country of Treatment > Puerto Rico

You are looking at 1 - 4 of 4 items

Andrea del Toro-Diez Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico

Search for other papers by Andrea del Toro-Diez in
Google Scholar
PubMed
Close
,
Ernesto Solá-Sánchez Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico

Search for other papers by Ernesto Solá-Sánchez in
Google Scholar
PubMed
Close
, and
Michelle Mangual-García Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico

Search for other papers by Michelle Mangual-García in
Google Scholar
PubMed
Close

Summary

Primary hypothyroidism is one of the most common endocrine disorders with widely available treatment. A minority of patients remain with uncontrolled hypothyroidism despite therapy. The objective of this case series was to demonstrate that medication non-adherence, rather than malabsorption, should be sought as the most common cause of unsuppressed TSH levels in patients receiving treatment for this condition. Non-adherence is often considered as a diagnosis of exclusion. Nonetheless, a diagnosis of malabsorption requires a more extensive workup, including imaging and invasive procedures, which increase healthcare costs and burden to the patient. The findings of this study allow for a cost-effective approach to uncontrolled hypothyroidism.

Learning points

  • Medication non-adherence is a common cause of insuppressible TSH levels.

  • Once weekly levothyroxine is an alternative approach to non-compliant patients.

  • Assessing compliance is more cost-effective and less burdensome than testing for malabsorption.

Open access
Nicolás Cruz-Dardíz Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico

Search for other papers by Nicolás Cruz-Dardíz in
Google Scholar
PubMed
Close
,
Nadyeschka Rivera-Santana Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico

Search for other papers by Nadyeschka Rivera-Santana in
Google Scholar
PubMed
Close
,
Marina Torres-Torres Internal Medicine Department, San Juan City Hospital, San Juan, Puerto Rico

Search for other papers by Marina Torres-Torres in
Google Scholar
PubMed
Close
,
Héctor Cintrón-Colón Internal Medicine Department, San Juan City Hospital, San Juan, Puerto Rico

Search for other papers by Héctor Cintrón-Colón in
Google Scholar
PubMed
Close
,
Shayanne Lajud Otolaryngology Head and Neck Surgery, University of Puerto Rico, Medical Science Campus, San Juan, Puerto Rico

Search for other papers by Shayanne Lajud in
Google Scholar
PubMed
Close
,
Ernesto Solá-Sánchez Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico

Search for other papers by Ernesto Solá-Sánchez in
Google Scholar
PubMed
Close
,
Michelle Mangual-García Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico

Search for other papers by Michelle Mangual-García in
Google Scholar
PubMed
Close
, and
Alex González-Bóssolo Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico

Search for other papers by Alex González-Bóssolo in
Google Scholar
PubMed
Close

Summary

Lingual thyroid (LT) gland is the most common type of ectopic thyroid tissue, but it is an extremely rare presentation. We present a case of a 41-year-old Hispanic female patient complaining of dysphonia and dysphagia. As part of the evaluation, fiber optic flexible indirect laryngoscopy (FIL) was performed which revealed a mass at the base of the tongue. The morphological examination was highly suspicious for ectopic thyroid tissue and the diagnosis was confirmed with neck ultrasound and thyroid scintigraphy. Although the patient presented subclinical hypothyroidism, levothyroxine therapy was initiated with a favorable response which included resolution of symptoms and mass size reduction. Our case portrays how thyroid hormone replacement therapy (THRT) may lead to a reduction in the size of the ectopic tissue and improvement of symptoms, thus avoiding the need for surgical intervention which could result in profound hypothyroidism severely affecting the patients’ quality of life.

Learning points:

  • Benign LT and malignant LT are indistinguishable clinically and radiographically for which histopathology is recommended.

  • THRT, radioactive iodine 131 (RAI) therapy, and surgical excision are potential management options for LT.

  • THRT may lead to size reduction of the ectopic tissue and resolution of symptoms avoiding surgical intervention.

Open access
Alex González Bóssolo Endocrinology, Diabetes and Metabolism

Search for other papers by Alex González Bóssolo in
Google Scholar
PubMed
Close
,
Michelle Mangual Garcia Endocrinology

Search for other papers by Michelle Mangual Garcia in
Google Scholar
PubMed
Close
,
Paula Jeffs González Endocrinology, Diabetes and Metabolism, San Juan City Hospital, Hato Rey Pathologies, San Juan, Puerto Rico

Search for other papers by Paula Jeffs González in
Google Scholar
PubMed
Close
,
Miosotis Garcia Endocrinology, Diabetes and Metabolism

Search for other papers by Miosotis Garcia in
Google Scholar
PubMed
Close
,
Guillermo Villarmarzo Endocrinology, Diabetes and Metabolism, San Juan City Hospital, Hato Rey Pathologies, San Juan, Puerto Rico

Search for other papers by Guillermo Villarmarzo in
Google Scholar
PubMed
Close
, and
Jose Hernán Martinez Endocrinology, Diabetes and Metabolism

Search for other papers by Jose Hernán Martinez in
Google Scholar
PubMed
Close

Summary

Classical papillary thyroid microcarcinoma (PTMC) is a variant of papillary thyroid carcinoma (PTC) known to have excellent prognosis. It has a mortality of 0.3%, even in the presence of distance metastasis. The latest American Thyroid Association guidelines state that although lobectomy is acceptable, active surveillance can be considered in the appropriate setting. We present the case of a 37-year-old female with a history of PTMC who underwent surgical management consisting of a total thyroidectomy. Although she has remained disease-free, her quality of life has been greatly affected by the sequelae of this procedure. This case serves as an excellent example of how first-line surgical treatment may result more harmful than the disease itself.

Learning points:

  • Papillary thyroid microcarcinoma (PTMC) has an excellent prognosis with a mortality of less than 1% even with the presence of distant metastases.

  • Active surveillance is a reasonable management approach for appropriately selected patients.

  • Patients should be thoroughly oriented about the risks and benefits of active surveillance vs immediate surgical treatment. This discussion should include the sequelae of surgery and potential impact on quality of life, especially in the younger population.

  • More studies are needed for stratification of PTMC behavior to determine if conservative management is adequate for all patients with this specific disease variant.

Open access
Ernesto Solá Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico, USA

Search for other papers by Ernesto Solá in
Google Scholar
PubMed
Close
,
Carmen Rivera Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico, USA

Search for other papers by Carmen Rivera in
Google Scholar
PubMed
Close
,
Michelle Mangual Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico, USA

Search for other papers by Michelle Mangual in
Google Scholar
PubMed
Close
,
José Martinez Endocrinology Department, San Juan City Hospital, San Juan, Puerto Rico, USA

Search for other papers by José Martinez in
Google Scholar
PubMed
Close
,
Kelvin Rivera Pulmonary Medicine Department, San Juan City Hospital, San Juan, Puerto Rico, USA

Search for other papers by Kelvin Rivera in
Google Scholar
PubMed
Close
, and
Ricardo Fernandez Pulmonary Medicine Department, San Juan City Hospital, San Juan, Puerto Rico, USA

Search for other papers by Ricardo Fernandez in
Google Scholar
PubMed
Close

Summary

Diabetes mellitus was identified as a risk factor for developing tuberculosis (TB) infection, and relapse after therapy. The risk of acquiring TB is described as comparable to that of HIV population. The fact that diabetics are 3× times more prone to develop pulmonary TB than nondiabetics cannot be overlooked. With DM recognized as global epidemic, and TB affecting one-third of the world population, physicians must remain vigilant. We present a 45-year-old woman born in Dominican Republic (DR), with 10-year history of T2DM treated with metformin, arrived to our Urgency Room complaining of dry cough for the past 3months. Interview unveiled unintentional 15lbs weight loss, night sweats, occasional unquantified fever, and general malaise but denied bloody sputum. She traveled to DR 2years before, with no known ill exposure. Physical examination showed a thin body habitus, otherwise well appearing woman with stable vital signs, presenting solely right middle lung field ronchi. LDH, ESR, hsCRP and Hg A1C were elevated. Imaging revealed a right middle lobe cavitation. Sputum for AFB disclosed active pulmonary TB. Our case portrays that the consideration of TB as differential diagnosis in diabetics should be exercised with the same strength, as it is undertaken during the evaluation of HIV patients with lung cavitation. Inability to recognize TB will endanger the patient, hospital dwellers and staff, and perpetuate this global public health menace.

Learning points

  • Diabetes mellitus should be considered an important risk factor for the reactivation of pulmonary tuberculosis.

  • High clinical suspicious should be taken into consideration as radiological findings for pulmonary tuberculosis in patients with diabetes mellitus may be atypical, involving middle and lower lobes.

  • Inability to recognize pulmonary tuberculosis will endanger the patient, hospital dwellers and staff, and perpetuate this global public health menace.

Open access